BLGBX | PRUUX | BLGBX / PRUUX | |
Total Expense Ratio | 0.00 | 0.09 | - |
Annual Report Gross Expense Ratio | 0.10 | 0.09 | 111% |
Fund Existence | 3 years | 8 years | - |
Gain YTD | 5.767 | 5.585 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 500000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.94B | 4.56B | 64% |
Annual Yield % from dividends | 4.29 | 4.06 | 106% |
Returns for 1 year | 0.34 | 0.18 | 184% |
Returns for 3 years | 4.13 | 2.61 | 158% |
Returns for 5 years | N/A | -43.49 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 24.34 | N/A | N/A |
Saratoga Health & Biotechnology I | |||
HRCIX | 72.23 | N/A | N/A |
Carillon ClariVest Capital Apprec I | |||
FHKAX | 55.46 | N/A | N/A |
Fidelity Advisor China Region A | |||
JLCVX | 77.90 | N/A | N/A |
JHancock Fundamental Large Cap Core R5 | |||
MAIHX | 21.02 | N/A | N/A |
Morgan Stanley Inst Passport ovrs eq IR |